key: cord-0720379-btyguuvp
authors: Dang, Nathalie Pham; Kappes, Florian; Pereira, Bruno; Barthélémy, Isabelle; Devoize, Laurent
title: Severe odontogenic infections drastically dropped during the COVID19-confinement: because hospitals became sanctuaries or because of the massive interruption in the consumption of NSAIDs?
date: 2020-10-29
journal: J Stomatol Oral Maxillofac Surg
DOI: 10.1016/j.jormas.2020.10.006
sha: 1bef8159a5495dbe2e39c9fdeeefb153905f651b
doc_id: 720379
cord_uid: btyguuvp

nan

oral and maxillofacial surgery, were expected to be drastically impacted. Surprisingly, this was not the case.

We decided to record retrospectively the number of patients admitted for odontogenic infection (acute apical abscess, periodontal abscess, pericoronitis, and cellulitis) to the dental emergency department of the University Hospital Center (UHC) of Clermont-Ferrand, France, and those hospitalized in the department of oral and maxillofacial surgery or transferred to the intensive care unit (ICU) of the UHC between March 17 and May 11 in the years 2015 to 2020. In 2020, 535 consultations for odontogenic infection requiring physical examination were recorded during the confinement period while between 2015 and 2019, 2693 patients (yearly mean 539 ± standard-deviation at 61) had consulted for the same reason (p = 0.902, one sample t-test). In 2020, severe odontogenic infection was recorded in 0.56% (3/535) of patients, and between 2015 and 2019 in 2.3% (61/2693) (p = 0.01, Chi-squared test). In 2020, no patient was admitted to the ICU for severe odontogenic infection as against 9 in the preceding 5 years (Fig.1 ). During the confinement period, we observed an equivalent number of consultations for odontogenic infection, but for less severe forms and no patient with a lifethreatening condition.

The number of patients treated for infectious disease in the dental emergency department has remained stable over the 6-year retrospective period of our study. However, it was widely expected that the cancellation of routine appointments with general dental practitioners along with patients' fear of contracting COVID-19 [2] in hospital would lead to delayed care and an increase in the severity of odontogenic infection [3] . In reaction to this speculation, we would like to make two objections.

The first is that the UHC of Clermont-Ferrand acquired sanctuary status. Events did not bear this out. Our region was little impacted by the Covid-19 pandemic. The number of patients that NSAIDs are associated with higher rates of complications after respiratory tract infections such as complicated pneumonia, pleural effusions, prolonged illness, peritonsillar abscess and dissemination [4] . A case-series reported that patients with severe odontogenic infection on NSAID therapy had a higher risk to develop mediastinitis or to be admitted to an ICU. However, the numerous clinical and epidemiologic studies concerning the potential risk of odontogenic infection developing into cervicofacial cellulitis through use of antiinflammatory drugs have not yet come to a clear-cut conclusion [5] , perhaps because it is impossible to evaluate the real consumption of NSAIDs (in terms of frequency and cumulative doses) in a given population. In our study, we observed that the mass decrease in NSAID consumption did not affect the number of odontogenic infections but seemed to have reduced their severity.

J o u r n a l P r e -p r o o f neuropathic. Although it has not been proven scientifically, oral and maxillofacial surgeons and odontologists are aware that NSAID prescription is not appropriate in cases of infectious pain because of a possible risk of worsening the infection. And yet, through ignorance or negligence, NSAIDs are commonly proposed by pharmacologists and general practitioners or self-prescribed by the patient, irrespective of the cause of the pain. In the light of the experience of the last few months, we are designing a "short screener" questionnaire to determine whether the patient has a purely inflammatory dental disease, such as pulpitis, or an infectious dental disease, so as to guide prescription of NSAIDs or antibiotic therapy pending consultation with a specialist.

J o u r n a l P r e -p r o o f

Morbidity and Cost of Odontogenic Infections

Fear and Practice Modifications among Dentists to Combat Novel Coronavirus Disease (COVID-19) Outbreak

The COVID-19 effect: number of patients presenting to The Mid Yorkshire Hospitals OMFS team with dental infections before and during The COVID-19 outbreak

Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients

Necrotizing Soft-Tissue Infections

Conflict of Interest: The authors declare that they have no conflict of interest.Acknowledgement to Pr Isabelle Barthélémy, Dr Candice Delbet-Dupas and Bruno Pereira